During the past decade, Yale Hemophilia Treatment Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yale Hemophilia Treatment Center" #1 collaborator was "American Thrombosis and Hemostasis Network" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Bioverativ Therapeutics Inc." with 1 trials as a collaborator, "CSL Behring" with 1 trials as a collaborator and "Shire" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Yale Hemophilia Treatment Center" are "Hemophilia" (1 trials) and "Hemophilia A" (1 trials). Many other conditions were trialed in "Yale Hemophilia Treatment Center" in a lesser frequency.

Most popular intervention types in "Yale Hemophilia Treatment Center" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013" (1 trials), "Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013" (1 trials) and "New FVIII products" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yale Hemophilia Treatment Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Yale Hemophilia Treatment Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Yale Hemophilia Treatment Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Yale Hemophilia Treatment Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".